Mounjaro from 139.00 Eli Lilly, 22.5% avg weight loss, available now Wegovy injection from 99.99 available now Wegovy pill MHRA approved, coming weeks Orforglipron coming late 2026 Retatrutide register interest, well notify you when available GPhC No
Newer agents tend to produce greater glucose lowering and weight loss, but may also cause more gastrointestinal symptoms during dose escalation
It can range from mild to severe and may last for a short time or continue throughout treatment
This study established the foundational benchmark for the Retatrutide vs Tirzepatide efficacy comparison in the scientific literature
To quickly treat hypoglycemia, eat or drink a fast-acting source of sugar (fruit juice, hard candy, crackers, raisins, or non-diet soda)
Diabetologia 61, 722726